NCT03369990View on ClinicalTrials.gov

DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy

PHASE2UnknownINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

December 31, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Benign Masseteric Hypertrophy
Interventions
DRUG

Botulinum toxin type A

Botulinum toxin type A(DWP450)

DRUG

Placebos

Normal Saline

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT03369990 - DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy | Biotech Hunter | Biotech Hunter